Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.

Hockenbery DM, Cruickshank S, Rodell TC, Gooley T, Schuening F, Rowley S, David D, Brunvand M, Berryman B, Abhyankar S, Bouvier M, McDonald GB.

Blood. 2007 May 15;109(10):4557-63. Epub 2007 Jan 23.

2.

Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD).

Castilla C, Pérez-Simón JA, Sanchez-Guijo FM, Díez-Campelo M, Ocio E, Pérez-Persona E, López-Villar O, Vazquez L, Caballero D, San Miguel JF.

Biol Blood Marrow Transplant. 2006 Sep;12(9):936-41.

3.

Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease.

Iyer RV, Hahn T, Roy HN, Battiwalla M, Cooper M, Anderson B, Paplham P, Brown K, Bambach B, Segal BH, McCarthy PL Jr.

Biol Blood Marrow Transplant. 2005 Aug;11(8):587-92.

5.

Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial.

McDonald GB, Bouvier M, Hockenbery DM, Stern JM, Gooley T, Farrand A, Murakami C, Levine DS.

Gastroenterology. 1998 Jul;115(1):28-35.

PMID:
9649455
6.

The use of oral beclomethasone dipropionate in the treatment of gastrointestinal graft-versus-host disease: the experience of the Fukuoka blood and marrow transplantation (BMT) group.

Takashima S, Eto T, Shiratsuchi M, Hidaka M, Mori Y, Kato K, Kamezaki K, Oku S, Henzan H, Takase K, Matsushima T, Takenaka K, Iwasaki H, Miyamoto T, Akashi K, Teshima T.

Intern Med. 2014;53(12):1315-20. Epub 2014 Jun 15.

7.

[Analysis of blood concentrations following oral administration of beclomethasone dipropionate for gut GVHD].

Ito T, Watanabe K, Nasu I, Ino K, Minowa M, Furusawa M, Okuno Y, Uchida Y, Miyazaki Y, Tamura H, Hasebe S, Takagi S, Yamamoto H, Matsuno N, Uchida N, Masuoka K, Wake A, Makino S, Taniguchi S, Hayashi M.

Gan To Kagaku Ryoho. 2010 Feb;37(2):267-70. Japanese.

PMID:
20154483
8.

Beclometasone oral--DOR BioPharma.

[No authors listed]

Drugs R D. 2007;8(2):91-4. Review.

PMID:
17324006
9.

Oral beclomethasone dipropionate for the treatment of gastrointestinal chronic graft-versus-host disease.

Villanueva FN, Pérez-Simón JA, Silva FF, Caballero-Velázquez TT, Sánchez-Guijo FF, Cañizo CC, Vázquez LL, Caballero DD, San Miguel JF.

Biol Blood Marrow Transplant. 2009 Oct;15(10):1331-6. doi: 10.1016/j.bbmt.2009.05.018. Epub 2009 Jul 22.

10.

Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study.

Rizzello F, Gionchetti P, D'Arienzo A, Manguso F, Di Matteo G, Annese V, Valpiani D, Casetti T, Adamo S, Prada A, Castiglione GN, Varoli G, Campieri M.

Aliment Pharmacol Ther. 2002 Jun;16(6):1109-16.

11.

Beclometasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease.

Díez-Campelo M, Sánchez-Guijo FM, Pérez-Simón JA.

Expert Opin Investig Drugs. 2008 Sep;17(9):1389-401. doi: 10.1517/13543784.17.9.1389 . Erratum in: Expert Opin Investig Drugs. 2008 Oct;17(10):1617. Simón, José A Pérez [corrected to Pérez-Simón, José A].

PMID:
18694371
12.

Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial.

Hings IM, Filipovich AH, Miller WJ, Blazar BL, McGlave PB, Ramsay NK, Kersey JH, Weisdorf DJ.

Transplantation. 1993 Sep;56(3):577-80.

PMID:
8212152
13.

A comparison of the effects of oral prednisone and inhaled beclomethasone dipropionate on circulating leukocytes.

Cameron RG, Black PN, Braan C, Browett PJ.

Aust N Z J Med. 1996 Dec;26(6):800-5.

PMID:
9028511
14.

Oral beclomethasone dipropionate as an initial treatment of gastrointestinal acute graft-versus-host disease after reduced-intensity cord blood transplantation.

Miura Y, Narimatsu H, Kami M, Kusumi E, Matsumura T, Yuji K, Wake A, Miyakoshi S, Taniguchi S.

Bone Marrow Transplant. 2006 Oct;38(8):577-9. Epub 2006 Sep 4. No abstract available.

PMID:
16953206
15.

Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease.

Baehr PH, Levine DS, Bouvier ME, Hockenbery DM, Gooley TA, Stern JG, Martin PJ, McDonald GB.

Transplantation. 1995 Dec 15;60(11):1231-8.

PMID:
8525516
16.

Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study.

Campieri M, Adamo S, Valpiani D, D'Arienzo A, D'Albasio G, Pitzalis M, Cesari P, Casetti T, Castiglione GN, Rizzello F, Manguso F, Varoli G, Gionchetti P.

Aliment Pharmacol Ther. 2003 Jun 15;17(12):1471-80.

17.

Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.

Van Lint MT, Milone G, Leotta S, Uderzo C, Scimè R, Dallorso S, Locasciulli A, Guidi S, Mordini N, Sica S, Cudillo L, Fagioli F, Selleri C, Bruno B, Arcese W, Bacigalupo A.

Blood. 2006 May 15;107(10):4177-81. Epub 2006 Jan 31.

18.

Evaluation of oral beclomethasone dipropionate for prevention of acute graft-versus-host disease.

Martin PJ, Furlong T, Rowley SD, Pergam SA, Lloid M, Schubert MM, Horgan KJ, Storer BE.

Biol Blood Marrow Transplant. 2012 Jun;18(6):922-9. doi: 10.1016/j.bbmt.2011.11.010. Epub 2011 Nov 9.

19.

Oral beclomethasone dipropionate as an initial treatment for stages 1-2 gastrointestinal tract acute graft-versus-host disease following unrelated cord blood transplantation.

Yamamoto H, Uchida N, Uchida Y, Nishida A, Ota H, Kageyama K, Nasu I, Wada S, Kaji D, Ishiwata K, Takagi S, Tsuji M, Asano-Mori Y, Matsuno N, Yamamoto G, Masuoka K, Izutsu K, Wake A, Yoneyama A, Makino S, Ito T, Hayashi M, Taniguchi S.

Ann Hematol. 2015 Dec;94(12):2073-5. doi: 10.1007/s00277-015-2483-z. Epub 2015 Sep 16. No abstract available.

PMID:
26374433
20.

Oral prolonged release beclomethasone dipropionate and prednisone in the treatment of active ulcerative colitis: results from a double-blind, randomized, parallel group study.

Van Assche G, Manguso F, Zibellini M, Cabriada Nuño JL, Goldis A, Tkachenko E, Varoli G, Kleczkowski D, Annese V, D'Heygere F, Balzano A; BETA study participating centers.

Am J Gastroenterol. 2015 May;110(5):708-15. doi: 10.1038/ajg.2015.114. Epub 2015 Apr 14. Erratum in: Am J Gastroenterol. 2015 Jun;110(6):943.

PMID:
25869389

Supplemental Content

Support Center